X SCRIBE THERAPEUTICS
Live / Registered — Registered (as of 17 Feb 2026)
What this means for you
Registered since 17 Feb 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Feb 2032: the §8 declaration of use).
Record
- Serial number
- 97473474
- Registration number
- 8145751
- Mark type
- Design + words
- Filed
- 23 Jun 2022
- Published for opposition
- 25 Apr 2023
- Registered
- 17 Feb 2026
- Next maintenance filing
- §8 declaration of use, due by 17 Feb 2032 (grace period to 17 Aug 2032)
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 042 — Scientific and technological services: Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, and therapeutic products and services; Design and development of engineered cells for use in scientific research and in drug discovery and development; Providing medical and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering
Owner
- Scribe Therapeutics Inc., Alameda, CA, US
- Scribe Therapeutics Inc., Alameda, CA, US
- Scribe Therapeutics Inc., Alameda, CA, US
Prosecution history
- 20 Aug 2026 — CORRECTION UNDER SECTION 7 - PROCESSED
- 10 Aug 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 May 2026 — TEAS SECTION 7 REQUEST RECEIVED
- 17 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 27 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Jun 2025 — USE AMENDMENT FILED
- 19 Dec 2025 — SOU EXTENSION 4 GRANTED
- 17 Jun 2025 — SOU EXTENSION 4 FILED
- 19 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 18 Jun 2025 — SOU TEAS EXTENSION RECEIVED